Most Recent
Novartis sues to stop generic version of blockbuster MS drug
Intellectual Property 2021-03-15 11:06 am By Cat Fredenburgh

Swiss drug giant Novartis has sued generic drug maker Pharmacor to halt its launch of a generic version of the company’s top-selling MS drug Gilenya.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Sandoz cross-claim seeks to block Merck Sharp & Dohme’s Januvia patent extension
Intellectual Property 2021-03-09 1:51 pm By Miklos Bolza

Generic pharmaceutical company Sandoz has hit back in an intellectual property lawsuit by Merck Sharp & Dohme, filing a cross-claim that seeks to undo an extension of time granted to the US drug manufacturer for a patent relating to its multibillion dollar Januvia and Janumet diabetes drugs.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

  1. Pages:
  3. 1
  4. 2